Emotional consequences of neuropathic pain: Insight from preclinical studies

Neuroscience and Biobehavioral Reviews

Volumn 47, Issue , 2014, Pages 154-164

  Yalcin, Ipek ^a   Barthas, Florent ^a,b   Barrot, Michel ^a  

^a CNRS   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Amygdala; Anterior cingulate cortex; Anxiety; Behavior; Chronic pain; Depression; Hippocampus; Insula; Neurocircuitry; Neuropathic pain; Nociception

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 1BETA; NEUROTROPHIC FACTOR;

AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ANXIETY DISORDER; DEPRESSION; GLIA CELL; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; INSULA; LIMBIC SYSTEM; LOCUS CERULEUS; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MONOAMINERGIC SYSTEM; NERVE CELL PLASTICITY; NEUROANATOMY; NEUROBIOLOGY; NEUROPATHIC PAIN; NONHUMAN; NORADRENERGIC SYSTEM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; ANIMAL; ANIMAL BEHAVIOR; ANXIETY; CHRONIC PAIN; COMPLICATION; EMOTION; HYPOPHYSIS ADRENAL SYSTEM; NEURALGIA; PHYSIOLOGY; PSYCHOLOGY;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; CHRONIC PAIN; DEPRESSION; EMOTIONS; NEURALGIA; PITUITARY-ADRENAL SYSTEM;

EID: 84906690352     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2014.08.002     Document Type: Review

References (187)

1. Al-Amin H., et al. Chronic dizocilpine or apomorphine and development of neuropathy in two animal models II: effects on brain cytokines and neurotrophins. Exp. Neurol. 2011, 228:30-40.
2. Alba-Delgado C., et al. Chronic pain leads to concomitant noradrenergic impairment and mood disorders. Biol. Psychiatry 2013, 73:54-62.
3. Alciati A., et al. Psychiatric problems in fibromyalgia: clinical and neurobiological links between mood disorders and fibromyalgia. Reumatismo 2012, 64:268-274.
4. Alheid G.F., et al. Amygdala and extended amydala. In the Rat Nervous System 1995, 495-578. Academic, San diego, CA. 2nd ed. G. Paxinos (Ed.).
5. Alkire M.T., et al. Dissociable brain activation responses to 5-Hz electrical pain stimulation: a high-field functional magnetic resonance imaging study. Anesthesiology 2004, 100:939-946.
6. Andersen M.L., Tufik S. Sleep patterns over 21-day period in rats with chronic constriction of sciatic nerve. Brain Res. 2003, 984:84-92.
7. Andrews N., et al. Spontaneous burrowing behaviour in the rat is reduced by peripheral nerve injury or inflammation associated pain. Eur. J. Pain 2012, 16:485-495.
8. Ansah O.B., et al. Influence of amygdaloid glutamatergic receptors on sensory and emotional pain-related behavior in the neuropathic rat. Behav. Brain Res. 2010, 209:174-178.
9. Antypa N., et al. The role of COMT gene variants in depression: bridging neuropsychological, behavioral and clinical phenotypes. Neurosci. Biobehav. Rev. 2013, 37:1597-1610.
10. Apkarian A.V., et al. Expression of IL-1beta in supraspinal brain regions in rats with neuropathic pain. Neurosci. Lett. 2006, 407:176-181.
11. Apkarian A.V., et al. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J. Neurosci. 2004, 24:10410-10415.
12. Attal N. Pharmacological treatment of neuropathic pain in primary care. Rev. Prat. 2013, 63:795-802.
13. Attal N., et al. Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion?. Pain 2008, 138:343-353.
14. Attal N., et al. The specific disease burden of neuropathic pain: results of a French nationwide survey. Pain 2011, 152:2836-2843.
15. Autry A.E., Monteggia L.M. Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol. Rev. 2012, 64:238-258.
16. Backonja M.M., et al. Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patients. J. Neuroimmunol. 2008, 195:157-163.
17. Bair M.J., et al. Depression and pain comorbidity: a literature review. Arch. Intern. Med. 2003, 163:2433-2445.
18. Baliki M.N., et al. Chronic pain and the emotional brain: specific brain activity associated with spontaneous fluctuations of intensity of chronic back pain. J. Neurosci. 2006, 26:12165-12173.
19. Baliki M.N., et al. Beyond feeling: chronic pain hurts the brain, disrupting the default-mode network dynamics. J. Neurosci. 2008, 28:1398-1403.
20. Baliki M.N., et al. Predicting value of pain and analgesia: nucleus accumbens response to noxious stimuli changes in the presence of chronic pain. Neuron 2010, 66:149-160.
21. Baliki M.N., et al. Corticostriatal functional connectivity predicts transition to chronic back pain. Nat. Neurosci. 2012, 15:1117-1119.
22. Balschun D., et al. Interleukin-6: a cytokine to forget. FASEB J. 2004, 18:1788-1790.
23. Barrot M. Tests and models of nociception and pain in rodents. Neuroscience 2012, 211:39-50.
24. Becerra L., et al. Reward circuitry activation by noxious thermal stimuli. Neuron 2001, 32:927-946.
25. Benbouzid M., et al. Sciatic nerve cuffing in mice: a model of sustained neuropathic pain. Eur. J. Pain 2008, 12:591-599.
26. Benedetti M., et al. Plasma corticosterone levels in mouse models of pain. Eur. J. Pain 2012, 16:803-815.
27. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988, 33:87-107.
28. Binder E.B., Nemeroff C.B. The CRF system, stress, depression and anxiety-insights from human genetic studies. Mol. Psychiatry 2010, 15:574-588.
29. Blom S.M., et al. Nerve injury-induced neuropathic pain causes disinhibition of the anterior cingulate cortex. J. Neurosci. 2014, 34:5754-5764.
30. Bomholt S.F., et al. Normal hypothalamo-pituitary-adrenal axis function in a rat model of peripheral neuropathic pain. Brain Res. 2005, 1044:216-226.
31. Bouhassira D., Attal N. Diagnosis and assessment of neuropathic pain: the saga of clinical tools. Pain 2011, 152:S74-S83.
32. Bouhassira D., et al. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain 2008, 136:380-387.
33. Boyle L.M. A neuroplasticity hypothesis of chronic stress in the basolateral amygdala. Yale J. Biol. Med. 2013, 86:117-125.
34. Bravo L., et al. Depressive-like states heighten the aversion to painful stimuli in a rat model of comorbid chronic pain and depression. Anesthesiology 2012, 117:613-625.
35. Bravo L. Pain exacerbates chronic mild stress-induced changes in noradrenergic transmission in rats. Eur. Neuropsychopharmacol. 2014, 24(6):996-1003.
36. Breivik H., et al. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur. J. Pain 2006, 10:287-333.
37. Brown G.M. Neuroendocrine probes as biological markers of affective disorders: new directions. Can. J. Psychiatry 1989, 34:819-823.
38. Calvo M., et al. The role of the immune system in the generation of neuropathic pain. Lancet Neurol. 2012, 11:629-642.
39. Capuron L., Miller A.H. Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol. Ther. 2011, 130:226-238.
40. Cardoso-Cruz H., et al. Impaired spatial memory performance in a rat model of neuropathic pain is associated with reduced hippocampus-prefrontal cortex connectivity. J. Neurosci. 2013, 33:2465-2480.
41. Carr F.B., Zachariou V. Nociception and pain: lessons from optogenetics. Front. Behav. Neurosci. 2014, 8:69.
42. Cassell M.D., et al. The intrinsic organization of the central extended amygdala. Ann. N. Y. Acad. Sci. 1999, 877:217-241.
43. Chang P.C., et al. Role of nucleus accumbens in neuropathic pain: linked multi-scale evidence in the rat transitioning to neuropathic pain. Pain 2014, 155(6). 1125-1119.
44. Chou C.W., et al. Peripheral nerve injury alters the expression of NF-kappaB in the rat's hippocampus. Brain Res. 2011, 1378:66-71.
45. Clark A.K., et al. Neuropathic pain and cytokines: current perspectives. J. Pain Res. 2013, 6:803-814.
46. Coghill R.C., et al. Pain intensity processing within the human brain: a bilateral, distributed mechanism. J. Neurophysiol. 1999, 82:1934-1943.
47. Cohen J.D., et al. Insular cortex abnormalities in psychotic major depression: relationship to gender and psychotic symptoms. Neurosci. Res. 2013, 75:331-339.
48. Colgin L.L., et al. Understanding memory through hippocampal remapping. Trends Neurosci. 2008, 31:469-477.
49. Colleoni M., Sacerdote P. Murine models of human neuropathic pain. Biochim. Biophys. Acta 2010, 1802:924-933.
50. Coull J.A., et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005, 438:1017-1021.
51. Covey W.C., et al. Brain-derived TNFalpha: involvement in neuroplastic changes implicated in the conscious perception of persistent pain. Brain Res. 2000, 859:113-122.
52. Covey W.C., et al. Expression of neuron-associated tumor necrosis factor alpha in the brain is increased during persistent pain. Reg. Anesth. Pain Med. 2002, 27:357-366.
53. Coyle J.T., Duman R.S. Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 2003, 38:157-160.
54. Dantzer R., et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
55. Decosterd I., Woolf C.J. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 2000, 87:149-158.
56. del Rey A., et al. Chronic neuropathic pain-like behavior correlates with IL-1beta expression and disrupts cytokine interactions in the hippocampus. Pain 2011, 152:2827-2835.
57. Dick B.D., Rashiq S. Disruption of attention and working memory traces in individuals with chronic pain. Anesth. Analg. 2007, 104:1223-1229. (tables of contents).
58. Drevets W.C. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr. Opin. Neurobiol. 2001, 11:240-249.
59. Drevets W.C., et al. Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders. Mol. Psychiatry 1998, 3(220-226):190-221.
60. Eisch A.J., Petrik D. Depression and hippocampal neurogenesis: a road to remission?. Science 2012, 338:72-75.
61. Elliott A.M., et al. The epidemiology of chronic pain in the community. Lancet 1999, 354:1248-1252.
62. Ferrini F., De Koninck Y. Microglia control neuronal network excitability via BDNF signalling. Neural Plast. 2013, 2013:429815.
63. Fietta P., Manganelli P. Fibromyalgia and psychiatric disorders. Acta Biomed. 2007, 78:88-95.
64. Finnerup N.B., et al. Recent advances in pharmacological treatment of neuropathic pain. F1000 Med. Rep. 2010, 2:52.
65. Freeman R., et al. Sensory profiles of patients with neuropathic pain based on the neuropathic pain symptoms and signs. Pain 2014, 155:367-376.
66. Fukuhara K., et al. Intracerebroventricular 4-methylcatechol (4-MC) ameliorates chronic pain associated with depression-like behavior via induction of brain-derived neurotrophic factor (BDNF). Cell. Mol. Neurobiol. 2012, 32:971-977.
67. Garcia-Larrea L., Peyron R. Pain matrices and neuropathic pain matrices: a review. Pain 2013, 154(Suppl. 1):S29-S43.
68. Goffer Y., et al. Calcium-permeable AMPA receptors in the nucleus accumbens regulate depression-like behaviors in the chronic neuropathic pain state. J. Neurosci. 2013, 33:19034-19044.
69. Goldberg J.S., et al. Revisiting the monoamine hypothesis of depression: a new perspective. Perspect. Medicin. Chem. 2014, 6:1-8.
70. Goncalves L., Dickenson A.H. Asymmetric time-dependent activation of right central amygdala neurones in rats with peripheral neuropathy and pregabalin modulation. Eur. J. Neurosci. 2012, 36:3204-3213.
71. Goncalves L., et al. Neuropathic pain is associated with depressive behaviour and induces neuroplasticity in the amygdala of the rat. Exp. Neurol. 2008, 213:48-56.
72. Greenspan J.D., Winfield J.A. Reversible pain and tactile deficits associated with a cerebral tumor compressing the posterior insula and parietal operculum. Pain 1992, 50:29-39.
73. Gustorff B., et al. Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey. Acta Anaesthesiol. Scand. 2008, 52:132-136.
74. Haanpaa M., et al. NeuPSIG guidelines on neuropathic pain assessment. Pain 2011, 152:14-27.
75. Hasnie F.S., et al. Further characterization of a rat model of varicella zoster virus-associated pain: relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs. Neuroscience 2007, 144:1495-1508.
76. Hasnie F.S., et al. Mechanical and cold hypersensitivity in nerve-injured C57BL/6J mice is not associated with fear-avoidance- and depression-related behaviour. Br. J. Anaesth. 2007, 98:816-822.
77. Hauger R.L., et al. Role of CRF receptor signaling in stress vulnerability, anxiety, and depression. Ann. N. Y. Acad. Sci. 2009, 1179:120-143.
78. Heim C., et al. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology 2000, 25:1-35.
79. Homberg J.R., Contet C. Deciphering the interaction of the corticotropin-releasing factor and serotonin brain systems in anxiety-related disorders. J. Neurosci. 2009, 29:13743-13745.
80. Hsieh J.C., et al. Central representation of chronic ongoing neuropathic pain studied by positron emission tomography. Pain 1995, 63:225-236.
81. Hu Y., et al. Amitriptyline rather than lornoxicam ameliorates neuropathic pain-induced deficits in abilities of spatial learning and memory. Eur. J. Anaesthesiol. 2010, 27:162-168.
82. Huang W., et al. A clinically relevant rodent model of the HIV antiretroviral drug stavudine induced painful peripheral neuropathy. Pain 2013, 154:560-575.
83. Ignatowski T.A., et al. Brain-derived TNFalpha mediates neuropathic pain. Brain Res. 1999, 841:70-77.
84. Ikeda R., et al. NMDA receptor-independent synaptic plasticity in the central amygdala in the rat model of neuropathic pain. Pain 2007, 127:161-172.
85. Jaggi A.S., et al. Animal models of neuropathic pain. Fundam. Clin. Pharmacol. 2011, 25:1-28.
86. Jain R., et al. Painful diabetic neuropathy is more than pain alone: examining the role of anxiety and depression as mediators and complicators. Curr. Diab. Rep. 2011, 11:275-284.
87. Karege F., et al. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res. Mol. Brain Res. 2005, 136:29-37.
88. Kastenberger I., et al. Influence of sex and genetic background on anxiety-related and stress-induced behaviour of prodynorphin-deficient mice. PLoS ONE 2012, 7:e34251.
89. Kavaliers M., Hirst M. Daily rhythms of analgesia in mice: effects of age and photoperiod. Brain Res. 1983, 279:387-393.
90. Kavaliers M., et al. Aging and daily rhythms of analgesia in mice: effects of natural illumination and twilight. Neurobiol. Aging 1984, 5:111-114.
91. Kenna G.A., et al. Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy. Pharmgenomics Pers. Med. 2012, 5:19-35.
92. Kilburn-Watt E., et al. Altered thyroid hormones and behavioural change in a sub-population of rats following chronic constriction injury. J. Neuroendocrinol. 2010, 22:960-970.
93. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992, 50:355-363.
94. Kim S.K., et al. Synaptic structure and function in the mouse somatosensory cortex during chronic pain: in vivo two-photon imaging. Neural Plast. 2012, 640259.
95. Kim S.K., Nabekura J. Rapid synaptic remodeling in the adult somatosensory cortex following peripheral nerve injury and its association with neuropathic pain. J. Neurosci. 2011, 31:5477-5482.
96. Kodama D., et al. Altered hippocampal long-term potentiation after peripheral nerve injury in mice. Eur. J. Pharmacol. 2007, 574:127-132.
97. Kodama D., et al. Increased hippocampal glycine uptake and cognitive dysfunction after peripheral nerve injury. Pain 2011, 152:809-817.
98. Kontinen V.K., et al. Behavioural measures of depression and anxiety in rats with spinal nerve ligation-induced neuropathy. Pain 1999, 80:341-346.
99. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455:894-902.
100. Krishnan V., Nestler E.J. Linking molecules to mood: new insight into the biology of depression. Am. J. Psychiatry 2010, 167:1305-1320.
101. Krystal A.D. Psychiatric disorders and sleep. Neurol. Clin. 2012, 30:1389-1413.
102. LaGraize S.C., Fuchs P.N. GABAA but not GABAB receptors in the rostral anterior cingulate cortex selectively modulate pain-induced escape/avoidance behavior. Exp. Neurol. 2007, 204:182-194.
103. Lalumiere R.T. Optogenetic dissection of amygdala functioning. Front. Behav. Neurosci. 2014, 8:107.
104. Lang U.E., Borgwardt S. Molecular mechanisms of depression: perspectives on new treatment strategies. Cell. Physiol. Biochem. 2013, 31:761-777.
105. LeDoux J.E. Emotion circuits in the brain. Annu. Rev. Neurosci. 2000, 23:155-184.
106. Legrain V., et al. A neurocognitive model of attention to pain: behavioral and neuroimaging evidence. Pain 2009, 144:230-232.
107. Leite-Almeida H., et al. The impact of age on emotional and cognitive behaviours triggered by experimental neuropathy in rats. Pain 2009, 144:57-65.
108. Leite-Almeida H., et al. Differential effects of left/right neuropathy on rats' anxiety and cognitive behavior. Pain 2012, 153:2218-2225.
109. Leite-Almeida H., et al. Asymmetric c-fos expression in the ventral orbital cortex is associated with impaired reversal learning in a right-sided neuropathy. Mol. Pain 2014, 10:41.
110. Li X.Y., et al. Alleviating neuropathic pain hypersensitivity by inhibiting PKMzeta in the anterior cingulate cortex. Science 2010, 330:1400-1404.
111. Liu J., et al. Quantitative cerebral blood flow mapping and functional connectivity of postherpetic neuralgia pain: a perfusion fMRI study. Pain 2013, 154:110-118.
112. Maarrawi J. Brain opioid receptor density predicts motor cortex stimulation efficacy for chronic pain. Pain 2013, 14(11):2563-2568.
113. Maletic V., Raison C.L. Neurobiology of depression, fibromyalgia and neuropathic pain. Front. Biosci. 2009, 14:5291-5338.
114. Marchant N.J., et al. Coexpression of prodynorphin and corticotrophin-releasing hormone in the rat central amygdala: evidence of two distinct endogenous opioid systems in the lateral division. J. Comp. Neurol. 2007, 504:702-715.
115. Matsuzawa-Yanagida K., et al. Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites. Neuropsychopharmacology 2008, 33:1952-1965.
116. Mazzola L., et al. Spatial segregation of somato-sensory and pain activations in the human operculo-insular cortex. Neuroimage 2012, 60:409-418.
117. McAllister A.K., et al. Neurotrophins and synaptic plasticity. Annu. Rev. Neurosci. 1999, 22:295-318.
118. Metz A.E., et al. Morphological and functional reorganization of rat medial prefrontal cortex in neuropathic pain. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2423-2428.
119. Miller A.H., et al. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009, 65:732-741.
120. Mor D., et al. Anatomically specific patterns of glial activation in the periaqueductal gray of the sub-population of rats showing pain and disability following chronic constriction injury of the sciatic nerve. Neuroscience 2010, 166:1167-1184.
121. Morrison I., et al. Facets and mechanisms of adaptive pain behavior: predictive regulation and action. Front. Hum. Neurosci. 2013, 7:755.
122. Mosconi T., Kruger L. Fixed-diameter polyethylene cuffs applied to the rat sciatic nerve induce a painful neuropathy: ultrastructural morphometric analysis of axonal alterations. Pain 1996, 64:37-57.
123. Mutso A.A., et al. Abnormalities in hippocampal functioning with persistent pain. J. Neurosci. 2012, 32:5747-5756.
124. Narita M., et al. Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology 2006, 31:739-750.
125. Narita M., et al. Chronic pain-induced emotional dysfunction is associated with astrogliosis due to cortical delta-opioid receptor dysfunction. J. Neurochem. 2006, 97:1369-1378.
126. Narita M., et al. Sleep disturbances in a neuropathic pain-like condition in the mouse are associated with altered GABAergic transmission in the cingulate cortex. Pain 2011, 152:1358-1372.
127. Nestler E.J., Carlezon W.A. The mesolimbic dopamine reward circuit in depression. Biol. Psychiatry 2006, 59:1151-1159.
128. Nestler E.J., Hyman S.E. Animal models of neuropsychiatric disorders. Nat. Neurosci. 2010, 13:1161-1169.
129. Ning L., et al. Chronic constriction injury induced long-term changes in spontaneous membrane-potential oscillations in anterior cingulate cortical neurons in vivo. Pain Physician 2013, 16:E577-E589.
130. Norman G.J., et al. Stress and IL-1beta contribute to the development of depressive-like behavior following peripheral nerve injury. Mol. Psychiatry 2010, 15:404-414.
131. Obermann M., et al. Gray matter volume reduction reflects chronic pain in trigeminal neuralgia. Neuroimage 2013, 74:352-358.
132. Ordway G.A., et al. Elevated tyrosine hydroxylase in the locus coeruleus of suicide victims. J. Neurochem. 1994, 62:680-685.
133. Ordway G.A., et al. Agonist binding to alpha 2-adrenoceptors is elevated in the locus coeruleus from victims of suicide. J. Neurochem. 1994, 63:617-624.
134. Ota K.T., Duman R.S. Environmental and pharmacological modulations of cellular plasticity: role in the pathophysiology and treatment of depression. Neurobiol. Dis. 2013, 57:28-37.
135. Palermo T.M., et al. Behavioral and psychosocial factors associated with insomnia in adolescents with chronic pain. Pain 2011, 152:89-94.
136. Pare D., Duvarci S. Amygdala microcircuits mediating fear expression and extinction. Curr. Opin. Neurobiol. 2012, 22:717-723.
137. Paulson P.E., et al. Long-term changes in behavior and regional cerebral blood flow associated with painful peripheral mononeuropathy in the rat. Pain 2002, 95:31-40.
138. Pedersen L.H., et al. Amygdala GABA-A receptor involvement in mediating sensory-discriminative and affective-motivational pain responses in a rat model of peripheral nerve injury. Pain 2007, 127:17-26.
139. Peyron R., et al. Functional imaging of brain responses to pain. A review and meta-analysis. Neurophysiol. Clin. 2000, 30:263-288.
140. Pittenger C., Duman R.S. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008, 33:88-109.
141. Poo M.M. Neurotrophins as synaptic modulators. Nat. Rev. Neurosci. 2001, 2:24-32.
142. Porro C.A., et al. Does anticipation of pain affect cortical nociceptive systems?. J. Neurosci. 2002, 22:3206-3214.
143. Poulin J.F., et al. Enkephalin knockdown in the central amygdala nucleus reduces unconditioned fear and anxiety. Eur. J. Neurosci. 2013, 37:1357-1367.
144. Qu C., et al. Lesion of the rostral anterior cingulate cortex eliminates the aversiveness of spontaneous neuropathic pain following partial or complete axotomy. Pain 2011, 152:1641-1648.
145. Radat F., et al. Psychiatric co-morbidities in patients with chronic peripheral neuropathic pain: a multicentre cohort study. Eur. J. Pain 2013, 17(10):1547-1554.
146. Raison C.L., Miller A.H. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am. J. Psychiatry 2003, 160:1554-1565.
147. Ren K., Torres R. Role of interleukin-1beta during pain and inflammation. Brain Res. Rev. 2009, 60:57-64.
148. Ren W.J., et al. Peripheral nerve injury leads to working memory deficits and dysfunction of the hippocampus by upregulation of TNF-alpha in rodents. Neuropsychopharmacology 2011, 36:979-992.
149. Roedel A., et al. Effects of light or dark phase testing on behavioural and cognitive performance in DBA mice. Lab. Anim. 2006, 40:371-381.
150. Roeska K., et al. Effect of high trait anxiety on mechanical hypersensitivity in male rats. Neurosci. Lett. 2009, 464:160-164.
151. Rouwette T., et al. Experimental neuropathy increases limbic forebrain CRF. Eur. J. Pain 2012, 16:61-71.
152. Russo S.J., Nestler E.J. The brain reward circuitry in mood disorders. Nat. Rev. Neurosci. 2013, 14:609-625.
153. Schneider H., et al. A neuromodulatory role of interleukin-1beta in the hippocampus. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:7778-7783.
154. Seltzer Z., et al. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 1990, 43:205-218.
155. Seminowicz D.A., et al. MRI structural brain changes associated with sensory and emotional function in a rat model of long-term neuropathic pain. Neuroimage 2009, 47:1007-1014.
156. Shackman A.J., et al. The integration of negative affect, pain and cognitive control in the cingulate cortex. Nat. Rev. Neurosci. 2011, 12:154-167.
157. Sliz D., Hayley S. Major depressive disorder and alterations in insular cortical activity: a review of current functional magnetic imaging research. Front. Hum. Neurosci. 2012, 6:323.
158. Sorkin L.S., Yaksh T.L. Behavioral models of pain states evoked by physical injury to the peripheral nerve. Neurotherapeutics 2009, 6:609-619.
159. Suzuki T., et al. Experimental neuropathy in mice is associated with delayed behavioral changes related to anxiety and depression. Anesth. Analg. 2007, 104:1570-1577. (table of contents).
160. Takeda K., et al. Effect of memantine on the levels of neuropeptides and microglial cells in the brain regions of rats with neuropathic pain. J. Mol. Neurosci. 2009, 39:380-390.
161. Takemura Y., et al. Effects of gabapentin on brain hyperactivity related to pain and sleep disturbance under a neuropathic pain-like state using fMRI and brain wave analysis. Synapse 2011, 65:668-676.
162. Tang N.K., et al. Deciphering the temporal link between pain and sleep in a heterogeneous chronic pain patient sample: a multilevel daily process study. Sleep 2012, 35:675-687A.
163. Terada M., et al. Suppression of enriched environment-induced neurogenesis in a rodent model of neuropathic pain. Neurosci. Lett. 2008, 440:314-318.
164. Toyoda H., et al. Enhanced quantal release of excitatory transmitter in anterior cingulate cortex of adult mice with chronic pain. Mol. Pain 2009, 5:4.
165. Treede R.D., et al. Cortical representation of pain: functional characterization of nociceptive areas near the lateral sulcus. Pain 2000, 87:113-119.
166. Treede R.D., et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008, 70:1630-1635.
167. Tsankova N.M., et al. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat. Neurosci. 2006, 9:519-525.
168. Uceyler N., et al. Early cytokine gene expression in mouse CNS after peripheral nerve lesion. Neurosci. Lett. 2008, 436:259-264.
169. Ulrich-Lai Y.M., et al. Limbic and HPA axis function in an animal model of chronic neuropathic pain. Physiol. Behav. 2006, 88:67-76.
170. Urban R., et al. Behavioral indices of ongoing pain are largely unchanged in male mice with tissue or nerve injury-induced mechanical hypersensitivity. Pain 2011, 152:990-1000.
171. Vadakkan K.I., et al. A behavioral model of neuropathic pain induced by ligation of the common peroneal nerve in mice. J. Pain 2005, 6:747-756.
172. Vartiainen N., et al. Changes in brain function and morphology in patients with recurring herpes simplex virus infections and chronic pain. Pain 2009, 144:200-208.
173. Veinante P., et al. The amygdala between sensation and affect: a role in pain. J. Mol. Psychiatry 2013, 1:14.
174. Vialou V., et al. DeltaFosB in brain reward circuits mediates resilience to stress and antidepressant responses. Nat. Neurosci. 2010, 13:745-752.
175. Vogt B.A. Pain and emotion interactions in subregions of the cingulate gyrus. Nat. Rev. Neurosci. 2005, 6:533-544.
176. Wallace V.C., et al. Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy. Pain 2007, 133:47-63.
177. Wallace V.C., et al. Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain. Brain 2007, 130:2688-2702.
178. Wallace V.C., et al. Anxiety-like behaviour is attenuated by gabapentin, morphine and diazepam in a rodent model of HIV anti-retroviral-associated neuropathic pain. Neurosci. Lett. 2008, 448:153-156.
179. Wang J., et al. A single subanesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats. Anesthesiology 2011, 115:812-821.
180. Wicking M., et al. Neuropsychological measures of hippocampal function. Front. Neurol. Neurosci. 2014, 34:60-70.
181. Wingenfeld K., Wolf O.T. Stress, memory, and the hippocampus. Front. Neurol. Neurosci. 2014, 34:109-120.
182. Xu H., et al. Presynaptic and postsynaptic amplifications of neuropathic pain in the anterior cingulate cortex. J. Neurosci. 2008, 28:7445-7453.
183. Yalcin I., et al. A time-dependent history of mood disorders in a murine model of neuropathic pain. Biol. Psychiatry 2011, 70:946-953.
184. Zeng Q., et al. Exacerbated mechanical allodynia in rats with depression-like behavior. Brain Res. 2008, 1200:27-38.
185. Zhao X.Y., et al. Nociception-induced spatial and temporal plasticity of synaptic connection and function in the hippocampal formation of rats: a multi-electrode array recording. Mol. Pain 2009, 5:55.
186. Zhu M.Y., et al. Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression. Biol. Psychiatry 1999, 46:1275-1286.
187. Zimmerman M.E., et al. Hippocampal correlates of pain in healthy elderly adults: a pilot study. Neurology 2009, 73:1567-1570.